Mark A. Hillman
Hillman Value Fund
Mark A. Hillman Zimmer Biomet Holdings Inc stake
total: 75
Hillman Value Fund ZBH trades
- Total transactions:
- 8
- New positions:
- 1
- Added:
- 2
- Reduced:
- 5
- Held since:
- 2021 Q4
- Held for:
- 18 quarters
- Latest activity:
- 2025 Q4
According to 2026 Q1 report, Mark A. Hillman holds 25,800 Zimmer Biomet Holdings Inc (ZBH) shares with a market value of roughly $2.33M accounting for 2.81% of the overall portfolio. To date, the estimated cost basis is nearly $122.11 for "buy" trades and estimated average "sell" price is $113.05. Hillman Value Fund first purchased ZBH in 2021 Q4, initially acquiring 47,000 shares. Since the initial investment in Zimmer Biomet Holdings Inc (ZBH), Hillman Value Fund has made 7 more transactions.
When did Mark A. Hillman buy Zimmer Biomet Holdings Inc (ZBH)?
Mark A. Hillman first invested in Zimmer Biomet Holdings Inc (ZBH) in 2021 Q4 at the reported quarter-end price of $127.04 per share.
What's the cost basis of Hillman Value Fund's ZBH stake?
The estimated cost basis for Zimmer Biomet Holdings Inc (ZBH) stake is around $122.11 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $122.11
- Weighted AVG sell price:
- $113.05
Mark A. Hillman's historical trades in Zimmer Biomet Holdings Inc
8 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q4
|
2.48%
|
25,800
|
$89.92
|
$2,319,936
|
-4.56% (-1,233)
|
-0.11%
|
|
2025 Q3
|
2.53%
|
27,033
|
$98.50
|
$2,662,750
|
-8.98% (-2,667)
|
-0.22%
|
|
2025 Q2
|
2.29%
|
29,700
|
$91.21
|
$2,708,937
|
-8.90% (-2,900)
|
-0.19%
|
|
2025 Q1
|
2.59%
|
32,600
|
$113.18
|
$3,689,668
|
-38.84% (-20,700)
|
-1.11%
|
|
2024 Q3
|
2.51%
|
53,300
|
$107.95
|
$5,753,735
|
+20.86% (+9,200)
|
+0.43%
|
|
2022 Q4
|
2.99%
|
44,100
|
$127.50
|
$5,622,750
|
-16.71% (-8,849)
|
-0.63%
|
|
2022 Q2
|
2.67%
|
52,949
|
$105.06
|
$5,562,822
|
+12.66% (+5,949)
|
+0.3%
|
|
2021 Q4
|
2.57%
|
47,000
|
$127.04
|
$5,970,880
|
new
|
+2.57%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.